Twitter_125

News : Latest News, Press Releases & Events

Your email address will not be published. Required fields are marked *

Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director January 16, 2018
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference November 1, 2017
HOPE-1 Clinical Trial for SPX-101 Is Enrolling CF Patients in Canada and Europe October 19, 2017
Spyryx Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of SPX-101 for the Treatment of Cystic Fibrosis October 18, 2017
Spyryx Biosciences Expands Development Award with Cystic Fibrosis Foundation; Presents Phase 1 Data for SPX-101 at the European Cystic Fibrosis Conference June 20, 2017
Spyryx Biosciences to Present at the 2017 Bio International Convention June 16, 2017